SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Isotechnika
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
285 8 0 ISA
Emcee:  schzammm Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
185Isotechnika Inc. receives No Objection Letter from Health Canada for Phase III pschzammm-12/1/2004
184EDMONTON, Nov 10, 2004 /PRNewswire-FirstCall via COMTEX/ -- Isotechnika Inc. anteevee-11/10/2004
183Frank, isotechnika.comteevee-11/9/2004
182It looks like ISA is getting ready to "cross the line". It's a nLetmebe Frank-11/8/2004
181Isotechnika Inc. achieves all endpoints in multiple ascending dose study for ISAteevee-11/3/2004
180Currently a nice move above resistance at C$2.00. "Hope springs eternal&qschzammm-11/2/2004
179I am in yesterday as an "investment" at $1.80 meaning long term..yearsgg cox-10/22/2004
178After reading the latest news release, I wonder if Ethyfarm and Biovail have an teevee-10/20/2004
177EDMONTON, Oct 20, 2004 (Canada NewsWire via COMTEX) -- Isotechnika Inc. announcteevee-10/20/2004
176Nice article about big pharmas but old news for ISA.schzammm-9/22/2004
175A Big Drug Maker Moves to Play Down Mass-Market Pills: Roche Seeks Pricey Producteevee-9/22/2004
174Isotechnika Inc. reports interim results of QTc trial biz.yahoo.com Isotechnikschzammm-9/9/2004
173<i>""Animal evidence suggests that conventional calcineurin immuteevee-9/6/2004
172Patients Receiving mTOR Inhibitors Exhibit Fewer Early Malignancies Than Those Rschzammm-9/6/2004
171FDA grants permission to Isotechnika for TAFA-93 clinical trial Wednesday July 7Icebrg-7/7/2004
170Positive data from Trans-ISA247 biz.yahoo.com EDMONTON, AB, July 6 /CNW/ - Isoschzammm-7/6/2004
169UPDATE - Isotechnika says narrowing search for drug partner Tuesday June 15, 12:Icebrg-6/15/2004
168EDMONTON, AB, June 15 /CNW/ - Isotechnika, Inc. (TSX:ISA), today announced that Icebrg-6/15/2004
167-- Sirolimus-based therapy following early cyclosporine withdrawal improves transchzammm-6/9/2004
166Isotechnika signs manufacturing agreement with Lonza Ltd. EDMONTON, AB, June 8 schzammm-6/8/2004
165Wall Street Reporter interview for May 20 wallstreetreporter.comteevee-5/22/2004
164Isotechnika receives no objection letter from Health Canada for TAFA-93 WednesdaIcebrg-5/19/2004
163biz.yahoo.com BOSTON, May 16 /PRNewswire/ -- Data presented today at a top U.S.schzammm-5/16/2004
162Jason, the fact that Roche is doing similar deals adds credence to ISA managemenschzammm-5/15/2004
161The restructured ISA247 deal may be like other deals Roche has been doing: Messatnsaf-5/15/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News